Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H6AsNO2.ClH |
Molecular Weight | 235.5 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NC1=CC(=CC=C1O)[As]=O
InChI
InChIKey=JRIGVWDKYXCHMG-UHFFFAOYSA-N
InChI=1S/C6H6AsNO2.ClH/c8-5-3-4(7-10)1-2-6(5)9;/h1-3,9H,8H2;1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C6H6AsNO2 |
Molecular Weight | 199.0389 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://doi.org/10.1089/aid.1990.6.1417
Sources: https://doi.org/10.1089/aid.1990.6.1417
Oxophenarsine was developed as an antisyphilis drug that can inhibit HIV-1 production. However, information about the further development of this drug is not available.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:58:56 GMT 2023
by
admin
on
Fri Dec 15 14:58:56 GMT 2023
|
Record UNII |
OG8JNR786U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
208-682-3
Created by
admin on Fri Dec 15 14:58:56 GMT 2023 , Edited by admin on Fri Dec 15 14:58:56 GMT 2023
|
PRIMARY | |||
|
m8317
Created by
admin on Fri Dec 15 14:58:56 GMT 2023 , Edited by admin on Fri Dec 15 14:58:56 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000166973
Created by
admin on Fri Dec 15 14:58:56 GMT 2023 , Edited by admin on Fri Dec 15 14:58:56 GMT 2023
|
PRIMARY | |||
|
OG8JNR786U
Created by
admin on Fri Dec 15 14:58:56 GMT 2023 , Edited by admin on Fri Dec 15 14:58:56 GMT 2023
|
PRIMARY | |||
|
10844
Created by
admin on Fri Dec 15 14:58:56 GMT 2023 , Edited by admin on Fri Dec 15 14:58:56 GMT 2023
|
PRIMARY | |||
|
538-03-4
Created by
admin on Fri Dec 15 14:58:56 GMT 2023 , Edited by admin on Fri Dec 15 14:58:56 GMT 2023
|
PRIMARY | |||
|
3087
Created by
admin on Fri Dec 15 14:58:56 GMT 2023 , Edited by admin on Fri Dec 15 14:58:56 GMT 2023
|
PRIMARY | |||
|
DTXSID50202077
Created by
admin on Fri Dec 15 14:58:56 GMT 2023 , Edited by admin on Fri Dec 15 14:58:56 GMT 2023
|
PRIMARY | |||
|
SUB181271
Created by
admin on Fri Dec 15 14:58:56 GMT 2023 , Edited by admin on Fri Dec 15 14:58:56 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |